Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.40p -11.57% 10.70p 10.40p 11.00p 13.40p 10.45p 12.25p 2,404,929 16:04:58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.9 -1.3 - 9.73

N4 Pharma Share Discussion Threads

Showing 5251 to 5272 of 5275 messages
Chat Pages: 211  210  209  208  207  206  205  204  203  202  201  200  Older
DateSubjectAuthorDiscuss
15/11/2018
10:32
blue finniisshhhhhh.........:)))
ch1rp
15/11/2018
10:16
Well a profit is a profit.can't blame em!
splatted
15/11/2018
09:43
Great, I'm trying to buy more but it's NT to buy all the time
dave4545
15/11/2018
09:41
Just shorted SKIN at .5p
takethat
15/11/2018
09:33
Potential next flier ticker SKIN...£1.4 mil market cap with rapidly increasing sales and moving to break even
dave4545
15/11/2018
08:47
More news coming soon and it will go up double price
thaohemmings4
15/11/2018
07:40
As nuvec evolves, NT will continue to lock up the patents here. They KNOW what they are doing:)))
ch1rp
15/11/2018
07:38
sounds exciting
remarkomsoc
15/11/2018
07:37
UK Regulatory (RNS & others) TIDMN4P RNS Number : 4038H N4 Pharma PLC 15 November 2018 15 November 2018 N4 Pharma Plc ("N4 Pharma" or the "Company") Filing of further Nuvec(R) patent application N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing a novel delivery system for vaccines and cancer treatments, is pleased to announce the filing of its Patent Cooperation Treaty ("PCT") patent application for its novel delivery system, Nuvec(R). Nuvec(R) is licensed by the Company from the University of Queensland under their silica nanoparticle patent application, which is currently under prosecution before various national patent offices. The patent application that was filed by the Company is based on improvements made to the manufacturing process, as the Company has scaled up production alongside specific examples of how Nuvec(R) can be used to improve delivery of nucleic acids. The Company's new PCT patent application claims priority from the Company's United Kingdom patent application number 1718817.8. The PCT application will publish approximately 18 months from the priority date of 14 November 2017. Therefore publication is expected on or shortly after 14 May 2019. National phase entry is due 30 months from the priority date, in most countries. The national phasing deadline is therefore expected to be 14 May 2020. Nigel Theobald, CEO of N4 Pharma commented: "Having strong intellectual property for Nuvec(R) is important for commercial outlicensing and this new PCT patent application not only strengthens the intellectual property rights around Nuvec(R) but, if granted, would provide an extra 30 months protection for Nuvec(R) after expiry of the in licensed IP which, if granted, would likely expire in April 2036. "As our work on Nuvec(R) progresses,we anticipate that subsequent patent applications will be filed to extend the protection for Nuvec(R) even further." Enquiries: N4 Pharma Plc Nigel Theobald, CEO Via Alma PR Allenby Capital Limited Tel: +44(0)203 328 5656 James Reeve/Virginia Bull/Asha Chotai Alma PR Josh Royston Tel: +44(0)778 090 1979 Robyn Fisher Tel: +44(0)754 070 6191
jakleeds
14/11/2018
14:20
And the bounce. Where to next? Nuvec news cannot be far away. The research program will not result in any financial benefit to the Company and the limited costs of the research, which are not expected to exceed GBP30,000, will be borne by N4 Pharma. Phase 1 is to test the delivery efficacy of combining the UoA cytolytic DNA vaccine with Nuvec(R) and will take around 4 weeks before proceeding into actual immunogenicity studies using different models, which would take a further 24 weeks. That is if they release the results of the efficacy or just roll on into the studies.
fireball xl5
14/11/2018
14:03
OEX bouncing back
stealive
14/11/2018
12:06
Agreed Splatted. Nothing wrong with the company nor where it is going. Just not today. Fortune will favour the LTHs:)))
ch1rp
14/11/2018
11:45
Its a classic trap for newbies,and most of them will never return.their only solace is that they got spiked on a good company.
splatted
14/11/2018
10:43
anyone managed to buy these this morning? My order with DEGIRO has not been filled yet a dummy selftrade order looks like it would go through.
jimbobaroony
14/11/2018
09:45
Predictable. I still cannot understand what draws so many to chase spikes so high. I mean paying 15p when it was 5p a few weeks ago why risk it in this market. Hundreds of stocks at their lows but nobody will touch them, mark them up 100-200% in a week or two and people cannot buy them fast enough. One day there will be no money left in this penny market, the mm's will have took it all, they suck millions out from people every week, it cannot sustain
dave4545
14/11/2018
09:38
Yea, certain loss for PI's and Xmas bonus for market makers, who should be obliged to explain any out of the ordinary movement in the price!
a1samu
14/11/2018
08:48
Price movement here over past fews days is crazy. There is as much sense for the massive drop as there was for the massive rise. This is gambling, not investing. Big risk, big rewards
jimbobaroony
14/11/2018
08:22
Excellent time for a top up methinks:)))
ch1rp
14/11/2018
01:45
Fireball, broker warrants were issued to Beaufort and Stockdale. Not near my home computer at the moment but the broker warrants amounted to 1,2??,??? so not a lot. I am assuming that most if not all of the warrants held with Stockdale clients would have been taken up by now and the Beaufort client warrants have been frozen for months until yesterday when they became tradable again and will run until May 3rd of next year.
hughwilson
14/11/2018
00:51
Thanks Hugh, so the Broker warrants, were they with Beaufort?
fireball xl5
13/11/2018
23:07
Nobbo. "Some contrition would be pleasing" Not half as pleasing as you coffing up the £200 which is now due for the bet you lost. Your refusal to pay up speaks volumes about you.
hughwilson
13/11/2018
23:03
Hugh, Watch and learn... Actually Hugh, you are right about the lock in period. Just rechecked the admission document. There, I acknowledged my mistake. Its not difficult.
jimbobaroony
Chat Pages: 211  210  209  208  207  206  205  204  203  202  201  200  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20181116 01:21:58